SCHEMBL5364576

SCHEMBL5364576

C/C(=C\C1(C(=O)OC2CC(C)CCC2C(C)C)CC1(C)C)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 3/20 0.44
ALDH1A1 P00352 7/20 0.41
HPGD P15428 2/20 0.41
CYP19A1 P11511 2/20 0.40
MAPT P10636 2/20 0.38
TSHR P16473 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
NFE2L2 Q16236 1/20 0.37
MAPK1 P28482 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
LMNA P02545 3/20 0.36
USP2 O75604 1/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
P2RX4 Q99571 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
MITF O75030 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5364579 1.00 EPHX1 (0.44) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL5365051 0.87 EPHX1 (0.44) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL5365056 0.87 EPHX1 (0.44) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL5373244 0.85 EPHX1 (0.43) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL5373249 0.85 EPHX1 (0.43) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL14809459 0.79 EPHX1 (0.50) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL19900547 0.76 EPHX1 (0.55) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL1073398 0.74 EPHX1 (0.43) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL1073394 0.74 EPHX1 (0.43) EPHX1ALDH1A1HPGDCYP19A1MAPT
SCHEMBL20719892 0.73 EPHX1 (0.52) EPHX1ALDH1A1HPGDCYP19A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7276622-B2 Method for producing oxygen-containing compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-10-02 US disclosed
US-20060173221-A1 Method for producing oxygen-containing compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-08-03 US disclosed
EP-1609777-A1 METHOD FOR PRODUCING OXYGEN-CONTAINING COMPOUND Sumitomo Chemical Company, Limited (JP) 2005-12-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060173221-A1 Method for producing oxygen-containing compound GPX4, DUOX2, SCO2 EPHX1 478/4885ALDH1A1 863/4885HPGD 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.